Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
The not-for-profits, some of which received as much as $10 million, include community centers, hunger relief agencies and social services groups. Most plan to use at least a portion of the money to create or fortify endowments.
The Indianapolis-based drugmaker’s purchase of the biotech firm CoLucid Pharmaceuticals will give it access to a late-stage experimental medication for migraine headaches.
The drug industry spends $5 billion a year pitching its pills and ointments to consumers. But it still finds itself on the defensive over high prices, so an industry group is trying to rescue its image.
Given his background, it’s not surprising that President Donald Trump gravitates to strong leaders. Many of his cabinet nominees served as either private-sector CEOs or military generals, executives with strong personalities and substantial experience at the top of large organizations. Closer to home, Indiana Gov. Eric Holcomb has selected some top aides from the private […]
President Trump took Big Pharma to task on pricing but also promised to ease regulations and find ways to speed medicines to market, which triggered a surge in the sector’s share prices.
Eli Lilly and Co. CEO Dave Ricks said he was encouraged by President Donald Trump’s understanding of the complexities of drug development, yet he’s concerned about risks the industry may face in a fresh overhaul of the U.S. health-care system.
One of only a few African-American women in biomedical science, Baindu Lucy Bayon is earning recognition for her own research and for her steadfast outreach to help open doors for others in STEM fields.
Leading teams in the Middle East, Europe, South America and East Asia, Jeffrey Wilson has risen through the ranks at Eli Lilly and Co. while also serving as board president for a vital United Way agency.
As technology permeates companies and industries, there is increasing talk that every company is becoming a tech company. So how are we to make sense of these blurring lines between businesses?
The Indianapolis Coalition for Patient Safety provides a forum for area hospitals to share information about best practices and work together to solve patient safety issues.
Two local men who have been working on a potential blockbuster treatment for a rare and debilitating disease are hopeful that a major injection of venture capital will provide the boost needed to move the drug to market—even if it means sweeping changes for their company.
A $17 million hotel should break ground in April, while plans for a parking garage could be followed by the construction of two office buildings that would cater to growing tech companies.
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
